SC bars Glenmark from making Merck’s drug
Posted on: 2015-05-16 Posted by: CLAT Gurukul Category: Archive Blog
In a relief to US pharma major Merck Sharp and Dohme, the Supreme Court restrained Indian firm Glenmark Pharmaceuticals from manufacturing and selling its anti-diabetes drugs Zita and Zita-Met. The apex court, however, allowed Glenmark Pharmaceuticals to continue selling existing stock of its anti-diabetes drugs Zita and Zita-Met in the market. Source: TOI Note: For more updates on topics asked in CLAT, keep visiting CLAT Gurukul which is a knowledge sharing initiative of The Knowledge Tree, Patna's premier coaching institute for CLAT and for other law entrance exams like AILET, SET, LSAT etc.